CRMD
Price
$9.13
Change
+$0.68 (+8.05%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
554.05M
14 days until earnings call
XLO
Price
$0.83
Change
+$0.04 (+5.06%)
Updated
Apr 24, 02:43 PM (EDT)
Capitalization
41.42M
13 days until earnings call
Ad is loading...

CRMD vs XLO

Header iconCRMD vs XLO Comparison
Open Charts CRMD vs XLOBanner chart's image
CorMedix
Price$9.13
Change+$0.68 (+8.05%)
Volume$29.96K
Capitalization554.05M
Xilio Therapeutics
Price$0.83
Change+$0.04 (+5.06%)
Volume$100
Capitalization41.42M
CRMD vs XLO Comparison Chart
Loading...
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRMD vs. XLO commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMD is a Buy and XLO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (CRMD: $8.44 vs. XLO: $0.80)
Brand notoriety: CRMD and XLO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRMD: 74% vs. XLO: 11%
Market capitalization -- CRMD: $554.05M vs. XLO: $41.42M
CRMD [@Biotechnology] is valued at $554.05M. XLO’s [@Biotechnology] market capitalization is $41.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRMD’s FA Score shows that 0 FA rating(s) are green whileXLO’s FA Score has 0 green FA rating(s).

  • CRMD’s FA Score: 0 green, 5 red.
  • XLO’s FA Score: 0 green, 5 red.
According to our system of comparison, XLO is a better buy in the long-term than CRMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRMD’s TA Score shows that 5 TA indicator(s) are bullish while XLO’s TA Score has 4 bullish TA indicator(s).

  • CRMD’s TA Score: 5 bullish, 3 bearish.
  • XLO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRMD is a better buy in the short-term than XLO.

Price Growth

CRMD (@Biotechnology) experienced а +12.30% price change this week, while XLO (@Biotechnology) price change was +5.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

CRMD is expected to report earnings on Aug 07, 2025.

XLO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRMD($554M) has a higher market cap than XLO($41.4M). CRMD YTD gains are higher at: 4.259 vs. XLO (-16.230). CRMD has higher annual earnings (EBITDA): -47.32M vs. XLO (-58M). XLO has more cash in the bank: 55.3M vs. CRMD (46M). CRMD has less debt than XLO: CRMD (556K) vs XLO (8.14M). CRMD has higher revenues than XLO: CRMD (12.3M) vs XLO (6.34M).
CRMDXLOCRMD / XLO
Capitalization554M41.4M1,338%
EBITDA-47.32M-58M82%
Gain YTD4.259-16.230-26%
P/E RatioN/AN/A-
Revenue12.3M6.34M194%
Total Cash46M55.3M83%
Total Debt556K8.14M7%
FUNDAMENTALS RATINGS
CRMD: Fundamental Ratings
CRMD
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRMDXLO
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 11 days ago
77%
Declines
ODDS (%)
Bearish Trend 21 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCLIX46.52N/A
N/A
Fidelity Advisor Industrials I
PQIAX36.70N/A
N/A
Principal Equity Income A
DWGFX10.92N/A
N/A
American Funds Dvlpg Wld Gr&Inc F1
TANDX36.37N/A
N/A
Castle Tandem No-Load
WBGSX7.24N/A
N/A
William Blair Growth N

CRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with MURA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then MURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
-0.65%
MURA - CRMD
41%
Loosely correlated
+1.84%
ARTL - CRMD
33%
Poorly correlated
-11.16%
RLYB - CRMD
32%
Poorly correlated
+4.79%
DNLI - CRMD
32%
Poorly correlated
+1.85%
XLO - CRMD
31%
Poorly correlated
-1.23%
More

XLO and

Correlation & Price change

A.I.dvisor tells us that XLO and CRMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XLO and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
-1.23%
CRMD - XLO
31%
Poorly correlated
-0.65%
AXON - XLO
31%
Poorly correlated
+3.82%
VKTX - XLO
30%
Poorly correlated
+1.22%
VTGN - XLO
27%
Poorly correlated
+5.85%
AVTX - XLO
27%
Poorly correlated
+1.64%
More